.svg){kind=small}
Dec-2025
Sales
Trend
6-Month
Product Count
SKUs
Overview
Market Insights Snapshot
Chronic Health has demonstrated a mixed performance across various categories and states. In the Arizona market, the brand maintained a strong presence in the Tincture & Sublingual category, holding steady at the second rank from September through November 2025, before slightly dropping to the third position in December. This indicates a consistent demand, although the slight dip suggests increased competition or shifting consumer preferences. Meanwhile, the sales figures for this category show a fluctuating trend, with a notable increase in December, suggesting a potential recovery or seasonal boost.
The Topical category in Arizona tells a different story, with Chronic Health experiencing a notable improvement in rankings. Starting from the third position in September, the brand slipped to fifth in October and November but made a significant leap to the second spot by December. This upward movement in the rankings is accompanied by a consistent increase in sales, culminating in a substantial rise in December. Such trends highlight the brand's resilience and adaptability in the face of market dynamics. However, the absence of Chronic Health in the top 30 in other states or categories suggests areas where the brand might need to focus more strategically to enhance its market presence.
Competitive Landscape
In the competitive landscape of the topical cannabis market in Arizona, Chronic Health has shown notable fluctuations in its ranking over the last few months of 2025. Despite starting strong in September with a third-place rank, Chronic Health experienced a dip to fifth place in both October and November. However, December saw a significant rebound as the brand surged to second place, indicating a positive trend in consumer preference or strategic adjustments. This upward movement is particularly impressive given the consistent dominance of Drip Oils + Extracts, which maintained the top position throughout this period. Meanwhile, Müv / MUV and Tru Infusion have also been strong contenders, with Müv / MUV slipping to third place in December and Tru Infusion closely trailing in fourth. Chronic Health's resurgence in December, marked by a significant increase in sales, suggests a strategic opportunity to capitalize on this momentum and potentially challenge the leading brands in the upcoming months.
Notable Products
In December 2025, the top-performing product for Chronic Health was the Indica THC Glycerin Tincture (100mg THC, 1oz) in the Tincture & Sublingual category, maintaining its first-place ranking from previous months with sales reaching 618 units. The CBD/THC 1:1 Glycerin Tincture (100mg CBD, 100mg THC, 1oz) secured the second position, consistently holding this spot since October 2025. The CBD/THC 1:1 Pain Relief Ointment (175mg CBD, 175mg THC, 2oz) ranked third, showing a steady climb from fourth place in September and October. The CBD/THC 1:1 Sleep Well Tincture (100mg CBD, 100mg THC, 1oz) remained in fourth place, having dropped from second place in September. Lastly, the CBD/THC 1:1 Pain Relief Ointment (45mg CBD, 45mg THC) consistently held the fifth rank throughout the four-month period.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
